169
Participants
Start Date
March 31, 2006
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
Ziprasidone oral capsules
Study medications will include oral ziprasidone capsules of 20 mg, 40 mg, 60 mg, and 80 mg strength. Subjects will be dosed daily for 26 weeks using a flexible dose design with a minimal dose range of 20mg bid to a maximum dose range of 80 mg bid .
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Decatur
Pfizer Investigational Site, Altamonte Springs
Pfizer Investigational Site, Orange City
Pfizer Investigational Site, Tavares
Pfizer Investigational Site, North Miami
Pfizer Investigational Site, Fort Lauderdale
Pfizer Investigational Site, Meridian
Pfizer Investigational Site, Lexington
Pfizer Investigational Site, Owensboro
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Terre Haute
Pfizer Investigational Site, Clinton Township
Pfizer Investigational Site, Milwaukee
Pfizer Investigational Site, West Allis
Pfizer Investigational Site, Omaha
Pfizer Investigational Site, Lincoln
Pfizer Investigational Site, Shreveport
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Tulsa
Pfizer Investigational Site, Plano
Pfizer Investigational Site, DeSoto
Pfizer Investigational Site, Arlington
Pfizer Investigational Site, Lake Jackson
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Scottsdale
Pfizer Investigational Site, Albuquerque
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Honolulu
Pfizer Investigational Site, Kirkland
Pfizer Investigational Site, Spokane
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Cleveland
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY